Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 119,658 | 104,554 | 83,529 | 38,791 | 51,442 |
| Operating Income | -119,658 | -104,554 | -83,529 | -38,791 | -51,442 |
| Other Income | 15,964 | 15,530 | 11,945 | 1,129 | 58 |
| Pre-tax Income | -103,694 | -89,024 | -71,584 | -37,662 | -51,384 |
| Net Income Continuous | -103,694 | -89,024 | -71,584 | -37,662 | -51,384 |
| Net Income | $-103,694 | $-89,024 | $-71,584 | $-37,662 | $-51,384 |
| EPS Basic Total Ops | -1.83 | -1.89 | -2.01 | -12.05 | -9.48 |
| EPS Basic Continuous Ops | -1.83 | -1.89 | -2.01 | -12.05 | -9.49 |
| EPS Diluted Total Ops | -1.83 | -1.89 | -2.01 | -12.05 | -9.48 |
| EPS Diluted Continuous Ops | -1.83 | -1.89 | -2.01 | -12.05 | -9.49 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.89 | -2.01 | 0.24 | -9.48 |
| EBITDA(a) | $-119,622 | $-103,813 | $-87,835 | $-38,576 | $-51,188 |